Member

Drossapharm AG

pharmazeutische Produkte

Drossapharm AG

Steinengraben 18
4051 Basel
Switzerland

Industries

Chemical & Pharmaceutical Technology

Life Science

Read more

Switzerland

Share

Related Content

Most of the 206 companies located in the cantons come from the information and communications technology (ICT) and life sciences sectors.

In 2023, 206 settlements across Switzerland were achieved through the cantonal, regional and national investment promotion offices. In the first ...

sustainability

Discounts on status assessments in the field of sustainability for exporting SMEs.

From left: Patrick Degelo, co-founder and CTO of Calopad, and Michael Breiter, co-founder and CEO of Calopad. Image credit: Calopad

Investors and a federal technology fund are giving more than 4 million Swiss francs to Calopad AG for its pain therapy. This will enable the star...

Official program

Export
Invest